XENO Cell Innovations
VerifiedBiocomputing for difficult screening applications.
Launch date
Employees
Market cap
-
Net debt
-
Enterprise valuation
$28—41m (Dealroom.co estimates Oct 2016.)
San Diego California (HQ)
| EUR | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|---|
| Revenues | 0000 | 0000 | 0000 | 0000 | 0000 | 0000 |
| % growth | - | - | - | 17 % | 71 % | 25 % |
| EBITDA | 0000 | 0000 | 0000 | 0000 | 0000 | 0000 |
| % EBITDA margin | 1517 % | - | 103 % | 36 % | - | - |
| Profit | 0000 | 0000 | 0000 | 0000 | 0000 | 0000 |
| % profit margin | (2764 %) | - | (109 %) | (78 %) | - | - |
| EV / revenue | 00.0x | 00.0x | 00.0x | 00.0x | 00.0x | 00.0x |
| EV / EBITDA | 00.0x | 00.0x | 00.0x | 00.0x | 00.0x | 00.0x |
| R&D budget | 0000 | 0000 | 0000 | 0000 | 0000 | 0000 |
| Date | Investors | Amount | Round |
|---|---|---|---|
| N/A | $6.9m | Series A | |
| Total Funding | 000k | ||
RELATED LANDSCAPES AND LISTS
Related Content
Recent News about XENO Cell Innovations
EditTech stack
Tech stackLearn more about the technologies and tools that this company uses.